People use this combo hoping it will speed up recovery from muscle tears, tendon injuries, sprains, and surgery
Naveed Sattar, professor of metabolic medicine at the University of Glasgow and chairs of the UK governments obesity mission, said it was difficult to establish "cause and effect" in single cases where patients die after taking the drugs
This is because the medication alters the digestive tract
Learn why you can trust us
Currently available GLP-1 receptor agonists in the UK include: For type 2 diabetes : semaglutide (Ozempic [injection], Rybelsus [oral tablet]), dulaglutide (Trulicity), liraglutide (Victoza), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia) For weight management : semaglutide 2.4 mg (Wegovy) and liraglutide 3 mg (Saxenda) Most GLP-1 medications are administered via subcutaneous injection, with dosing frequencies ranging from daily to once weekly depending on the specific formulation